Unibios Laboratories Limited
This company manufactures pharmaceutical formulations for domestic and international markets, with a wide range of products.
1991 | Mumbai, Maharashtra (India) | Under Liquidation
Unibios Laboratories Profile
Key Indicators
- Authorised Capital ₹ 30.00 Cr
- Paid Up Capital ₹ 17.43 Cr
- Company Age 33 Year, 10 Months
- Last Filing with ROC 31 Mar 2014
- Open Charges ₹ 45.95 Cr
- Satisfied Charges ₹ 85.51 Cr
About Unibios Laboratories
Unibios Laboratories Limited (ULL) is Under Liquidation company established on 24 Apr 1991 with its office registered at Mumbai, Maharashtra, India and has been running since 33 Year, 10 Months with a paid up capital of 17.43 Cr. According to MCA records, 3 Directors are linked to this company as of 26 Apr 2024.
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24230MH1991PLC061362
- Company No.
061362
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
24 Apr 1991
- Date of AGM
30 Sep 2014
- Date of Balance Sheet
31 Mar 2014
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Pharma
Who are the key members and board of directors at Unibios Laboratories?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rajkumar Chawla  | Managing Director | 26-Oct-1993 | Current |
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sunil Deshpande | Whole-Time Director | 01-Nov-2006 | Current |
| Bishan Tandon | Director | 01-Nov-2006 | Current |
Financial Performance of Unibios Laboratories.
Enhance accessibility to Unibios Laboratories's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Unibios Laboratories?
Unlock access to Unibios Laboratories's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
Open Charges
₹45.95 Cr
Satisfied Charges
₹85.51 Cr
Charges Breakdown by Lending Institutions
- State Bank Of India : 45.95 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 02 Jun 2009 | State Bank Of India | ₹45.95 Cr | Open |
| 23 Feb 2011 | S. E. Investments Limited | ₹1.40 Cr | Satisfied |
| 01 Dec 2006 | Bank Of India | ₹8.00 M | Satisfied |
| 10 Apr 2006 | Indian Overseas Bank | ₹1.64 Cr | Satisfied |
| 29 Mar 2006 | Indian Overseas Bank | ₹1.64 Cr | Satisfied |
How Many Employees Work at Unibios Laboratories?
Unibios Laboratories has a workforce of 9 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Unibios Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Unibios Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
